Cencora, Inc. (COR) reported earnings for first quarter that decreased from last year but beat the Street estimates. The company's ...
Leerink analyst Michael Cherny raised the firm’s price target on Cencora (COR) to $301 from $287 and keeps an Outperform rating on the shares ...
CONSHOHOCKEN, Pa., February 07, 2025--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings ...
Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...
Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said ...
The company said that it now owns a 6% stake in Cencora, trimming it down from 10% it previously held. It sold Cencora shares worth $1.1 billion in August. Walgreens has sold about $265 million worth ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. In yet another move to pay down debt that matures in ...
Cencora has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale ...